Literature DB >> 34387197

Association of Elective Surgical Volume with State Executive Order Curtailing Elective Surgery in Michigan During the COVID-19 Pandemic.

Ryan E Eton1, Monica L Yost, Michael P Thompson, Nicholas H Osborne, Hari Nathan, Michael J Englesbe, Craig S Brown.   

Abstract

OBJECTIVE: Our objective was to evaluate changes in elective surgical volume in Michigan while an Executive Order (EO) was in place curtailing elective surgery during the COVID-19 pandemic. SUMMARY BACKGROUND DATA: Many state governors enacted EOs curtailing elective surgery to protect scare resources and generate hospital capacity for patients with COVID-19. Little is known of the effectiveness of an EO on achieving a sustained reduction in elective surgery.
METHODS: This retrospective cohort study of data from a statewide claims-based registry in Michigan includes claims from the largest private payer in the state for a representative set of elective operations on adult patients from February 2 through August 1, 2020. We reported trends in surgical volume over the period the EO was in place. Estimated backlogs in elective surgery were calculated using case counts from the same period in 2019.
RESULTS: Hospitals achieved an 91.7% reduction in case volume before the EO was introduced. By the time the order was rescinded, hospitals were already performing elective surgery at 60.1% of pre-pandemic case rates. We estimate that a backlog of 6,419 operations was created while the EO was in effect. Had hospitals ceased elective surgery during this period, an additional 18% of patients would have experienced a delay in surgical care.
CONCLUSIONS: Both the introduction and removal of Michigan's EO lagged behind the observed ramp-down and ramp-up in elective surgical volume. These data suggest that EOs may not effectively modulate surgical care and could also contribute to unnecessary delays in surgical care.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 34387197      PMCID: PMC8840988          DOI: 10.1097/SLA.0000000000005150

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  6 in total

1.  Validation of a claims-based algorithm to characterize episodes of care.

Authors:  Chad Ellimoottil; John D Syrjamaki; Benedict Voit; Vinay Guduguntla; David C Miller; James M Dupree
Journal:  Am J Manag Care       Date:  2017-11-01       Impact factor: 2.229

2.  Drivers of Variation in 90-Day Episode Payments After Percutaneous Coronary Intervention.

Authors:  Devraj Sukul; Milan Seth; James M Dupree; John D Syrjamaki; Andrew M Ryan; Brahmajee K Nallamothu; Hitinder S Gurm
Journal:  Circ Cardiovasc Interv       Date:  2019-01       Impact factor: 6.546

3.  Response of US hospitals to elective surgical cases in the COVID-19 pandemic.

Authors:  Romain Pirracchio; Orestes Mavrothalassitis; Michael Mathis; Sachin Kheterpal; Matthieu Legrand
Journal:  Br J Anaesth       Date:  2020-10-19       Impact factor: 9.166

4.  Balancing revenue generation with capacity generation: case distribution, financial impact and hospital capacity changes from cancelling or resuming elective surgeries in the US during COVID-19.

Authors:  Joseph E Tonna; Heidi A Hanson; Jessica N Cohan; Marta L McCrum; Joshua J Horns; Benjamin S Brooke; Rupam Das; Brenna C Kelly; Alexander John Campbell; James Hotaling
Journal:  BMC Health Serv Res       Date:  2020-12-03       Impact factor: 2.655

5.  The likely economic impact of fewer elective surgical procedures on US hospitals during the COVID-19 pandemic.

Authors:  Matthew J Best; Edward G McFarland; Gerard F Anderson; Uma Srikumaran
Journal:  Surgery       Date:  2020-07-29       Impact factor: 3.982

6.  Modeling the elective vascular surgery recovery after coronavirus disease 2019: Implications for moving forward.

Authors:  Craig S Brown; Jeremy Albright; Peter K Henke; M Ashraf Mansour; Mitchell Weaver; Nicholas H Osborne
Journal:  J Vasc Surg       Date:  2020-11-25       Impact factor: 4.268

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.